Results 101 to 110 of about 9,231 (199)
Transfusion, EarlyView.Abstract Background Newly positive hepatitis B virus (HBV) serologic results after allogeneic hematopoietic cell transplantation (HCT) may reflect passive antibody transfer from blood‐derived products rather than HBV infection. We investigated the incidence and temporal patterns of hepatitis B surface antibody (anti‐HBs) and antibody to hepatitis B ...
Takaaki Konuma +7 more
wiley +1 more source
Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis
Journal of Hematology & Oncology, 2017 We studied non-driver mutations in 62 subjects with myeloproliferative neoplasm (MPN)-associated myelofibrosis upon diagnosis, including 45 subjects with primary myelofibrosis (PMF) and 17 with post-polycythemia vera or post-essential thrombocythemia ...
Bing Li +11 more
doaj +1 more source
Ruxolitinib for Myelofibrosis [PDF]
New England Journal of Medicine, 2012 Steffen, Koschmieder +2 more
openaire +5 more sources
, 2018 An image from a peripheral blood smear showing tears, elliptocytes, and schistocytes seen in a patient with primary myelofibrosis (50X oil immersion). A blast is also present (center)
To, Michelle, Kwon, Gloria
core +1 more source
Veterinary and Comparative Oncology, EarlyView.ABSTRACT Studies describing feline myeloma related diseases (MRD) are limited and reported prognostic indicators are inconsistent. Cats more commonly exhibit visceral plasma cell tumours (PCTs) than marrow‐predominant disease, suggesting that diagnostic approaches adapted from the International Myeloma Working Group (IMWG) criteria, incorporating ...
Christina M. Jeffries +5 more
wiley +1 more source
, 2018 An image from a peripheral blood smear showing tears, elliptocytes, and schistocytes seen in a patient with primary myelofibrosis (50X oil immersion).
To, Michelle, Kwon, Gloria
core +1 more source
ADVANCED THERAPY IN PATIENTS WITH PRIMARY AND POSTPOLYCYTHEMIC MYELOFIBROSIS [PDF]
, 2017 Ph-negative myeloproliferative neoplasm are the group of hematologic disorders which includes primary myelofibrosis, polycythemia vera, essential trombocytemia and several rare diseases.
O. E. Ochirova +3 more
core +1 more source
SLE Complicated With AIHA and Parvovirus B19 Infection Secondary to PRCA: A Case Report
Clinical Case Reports, Volume 14, Issue 11, November 2026.We report the diagnosis and treatment process of a female with SLE and AIHA infected with parvovirus B19 and secondary PRCA. Interestingly, there was no significant increase in hemoglobin after IVIG treatment for more than 50 days; however, the addition of foscarnet showed good efficacy.
Mingquan Xing +4 more
wiley +1 more source
Clozapine‐Associated Neutropenia With COVID‐19 Infection and the Role of Filgrastim
Progress in Neurology and Psychiatry, Volume 30, Issue 4, November 2026.ABSTRACT Clozapine is the gold standard, evidence‐based treatment of choice for treatment‐resistant schizophrenia. However, clozapine can induce serious, life‐threatening adverse effects, including neutropenia and agranulocytosis. There is accumulating evidence to suggest that rechallenging with clozapine should be considered in most patients with ...
Devender Singh Yadav
wiley +1 more source
Genome Aging in Women: Hematopoietic Loss of X Chromosome as An Exemplar
Aging Cell, Volume 25, Issue 11, November 2026.As studies at the intersection of genetics and aging are rapidly advancing, genome aging provides a novel mechanism by which aging phenotypes occur. In this Review, the authors examine the rise, expansion, and the consequences of X chromosome loss in female blood cells.
Xihan Guo, Xueqin Dai
wiley +1 more source